ConductScience.org, home

Paper39883133

Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome.

Guaragna MS and 9 others. Pediatr Nephrol, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome. Papers, record 39883133. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39883133

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Past and future in vitro and in vivo approaches toward circulating factors and biomarkers in idiopathic nephrotic syndrome.
PubMed
Journal
Pediatr Nephrol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-03
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Nephrotic SyndromeMajor topic
Renal Insufficiency, ChronicMajor topic
Humans
Biomarkers
Disease Progression
Kidney Transplantation
Child
Immunosuppressive Agents
Recurrence
Animals
Drug Resistance

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2013/02162-8Fundação de Amparo à Pesquisa do Estado de São PauloPubMed
2014/27198-8Fundação de Amparo à Pesquisa do Estado de São PauloPubMed
2020/15800-6Fundação de Amparo à Pesquisa do Estado de São PauloPubMed

Source PubMed

Download CSV of grants

References87

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121380797Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.Pediatr Nephrol2011https://conductscience.org/library/papers/21380797PubMed
215149356Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes.Kidney Int2004https://conductscience.org/library/papers/15149356PubMed
322533598Resolution of recurrent focal segmental glomerulosclerosis after retransplantation.N Engl J Med2012https://conductscience.org/library/papers/22533598PubMed
426697460Circulating CD40 autoantibody and suPAR synergy drives glomerular injury.Ann Transl Med2015https://conductscience.org/library/papers/26697460PubMed
531853790Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier.J Nephrol2020https://conductscience.org/library/papers/31853790PubMed
612461559uPAR: a versatile signalling orchestrator.Nat Rev Mol Cell Biol2002https://conductscience.org/library/papers/12461559PubMed
736952039What is circulating factor disease and how is it currently explained?Pediatr Nephrol2023https://conductscience.org/library/papers/36952039PubMed
826668027Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.Clin J Am Soc Nephrol2016https://conductscience.org/library/papers/26668027PubMed
931076096Circulating factors cause proteinuria in parabiotic zebrafish.Kidney Int2019https://conductscience.org/library/papers/31076096PubMed
109344605Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines.Exp Cell Res1997https://conductscience.org/library/papers/9344605PubMed
1126924225Three-dimensional podocyte-endothelial cell co-cultures: Assembly, validation, and application to drug testing and intercellular signaling studies.Eur J Pharm Sci2016https://conductscience.org/library/papers/26924225PubMed
126383672Increased urinary protein excretion in the rat produced by serum from a patient with recurrent focal glomerular sclerosis after renal transplantation.Clin Nephrol1984https://conductscience.org/library/papers/6383672PubMed
1325278092B7-1 immunostaining in proteinuric kidney disease.Am J Kidney Dis2014https://conductscience.org/library/papers/25278092PubMed
1438804512Autoantibodies Targeting Nephrin in Podocytopathies.N Engl J Med2024https://conductscience.org/library/papers/38804512PubMed
1516079987Altered activity of plasma hemopexin in patients with minimal change disease in relapse.Pediatr Nephrol2005https://conductscience.org/library/papers/16079987PubMed
1631575677Kidney organoids: accurate models or fortunate accidents.Genes Dev2019https://conductscience.org/library/papers/31575677PubMed
1728992235Treatment by immunoadsorption for recurrent focal segmental glomerulosclerosis after paediatric kidney transplantation: a multicentre French cohort.Nephrol Dial Transplant2018https://conductscience.org/library/papers/28992235PubMed
1810446937Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF.J Am Soc Nephrol1999https://conductscience.org/library/papers/10446937PubMed
1932477353CASK, the Soluble Glomerular Permeability Factor, Is Secreted by Macrophages in Patients With Recurrent Focal and Segmental Glomerulo-Sclerosis.Front Immunol2020https://conductscience.org/library/papers/32477353PubMed
2010544870The FSGS factor: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma.Clin Pediatr (Phila)1999https://conductscience.org/library/papers/10544870PubMed

See all 87 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41906863Recurrence of focal segmental glomerulosclerosis: An updated review of pathophysiology, biomarkers, and therapeutic strategies.Cell Transplant2026https://conductscience.org/library/papers/41906863

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39883133

GET https://conductscience.org/api/papers/v1/39883133/references?page=2